The U.S. government's first-ever negotiated prices for prescription drugs are still on average more than double, and in some cases five times, what drugmakers have agreed
September 03, 2024
Gilead Sciences on Thursday reported second-quarter profit that handily beat Wall Street estimates, driven by lower operating expenses and higher product sales, and the
August 08, 2024
Amgen on Tuesday said its second-quarter profit slipped 1% as higher expenses, including costs related to development of its experimental obesity drug MariTide, offset a 20
August 06, 2024
Gilead Sciences reported a first-quarter loss on Thursday after taking a $3.9 billion charge for its recent acquisition of liver drug developer CymaBay Therapeutics, while
April 25, 2024Pharmaceutical companies last year launched new U.S. drugs at prices 35% higher than in 2022, reflecting in part the industry's embrace of expensive therapies for rare
April 26, 2024
Health insurer Cigna is in merger talks with Humana, a source familiar with the matter said on Wednesday, potentially marking the latest in a long string of deals aimed at
April 26, 2024
Drugmaker Gilead Sciences on Tuesday said third-quarter sales were little changed from a year earlier, but earnings rose 21% due mainly to lower taxes.
April 26, 2024
Amgen, which earlier this month acquired Horizon Therapeutics for $27.8 billion, on Tuesday said its third-quarter product sales rose 5% as double-digit volume growth was
April 26, 2024
As millions seek access to weight-loss drugs from Novo Nordisk and Eli Lilly, increasing supplies, possible wider usage and a growing number of would-be rivals are leading
May 28, 2024
Amgen investors eyeing dramatic share price gains for rivals with successful obesity drugs will be focused on any updates the biotech company may provide on its own weight-
May 16, 2024
Amgen on Thursday said it was very encouraged after completing an interim analysis of its mid-stage study of experimental weight-loss drug MariTide and will no longer
May 17, 2024
Bristol Myers Squibb reported a first-quarter loss on Thursday as charges related to its acquisitions of Karuna Therapeutics, RayzeBio and Mirati
April 25, 2024
A U.S. government research team found no significant evidence of brain injury among a group of federal employees reporting symptoms of the "Havana syndrome" ailment that
March 18, 2024
DOJ launches civil rights probe of Mississippi sheriff’s office whose deputies tortured 2 Black men in ‘Goon Squad’ case
Alaska man arrested for threatening six US Supreme Court justices
Hershey Co lays off some workers this week
Israeli soldiers pushed three apparently lifeless bodies from roofs during a West Bank raid
Dolphins dying again in Amazon lake made shallow by drought
German tax revenue rose by 5.3% in August
JPMorgan names heads for healthcare, tech investment banking
Cat travels over 1,000 miles back home after going missing in Yellowstone
Feathered firefighter: Lost duck finds home at Tuscaloosa fire station
Halloween shoppers hunt for early deals while total spending eases, survey shows